Reply to Dr. Sredni and Colleagues
- 作者Ryuji Fukuzawa; Rosemary W. Heathcott; Ian M. Morison; Anthony E. Reeve; Makoto Sano
- 卷第7卷
- 期第6期
- 印刷ISSN1093-5266
- 电子ISSN1615-5742
- 文件大小29.54KB
- 发表时间2004-12
- DOI10.1007/s10024-004-8093-8
- 页码670-670
Cytomorphological Features of Epstein Barr Virus-Related Lymphoproliferative Disorder Associated With Epstein Barr Virus-Positive Mucocutaneous UlcerSzporn, Arnold H.; Chen, Hua; Liu, Hui; Ward, Stephen; Patel, Kalpesh; Strauchen, James · American Journal of Clinical Pathology · 2012
Epstein Barr virus-associated lymphoproliferative diseases: the virus as a therapeutic targetE. Tse; Y. Kwong · 2015
The Cutaneous Lymphoid Proliferations || Epstein–Barr Virus-Associated Lymphoproliferative DiseaseMagro, Cynthia M.; Crowson, A. Neil; Mihm, Martin C. · 2007
Immune-cell treatment of Epstein–Barr-virus-associated lymphoproliferative disordersLode J. Swinnen · 2006
Immunotherapeutic options for Epstein–Barr virus-associated lymphoproliferative disease following transplantationShaffer, Donald R; Rooney, Cliona M; Gottschalk, Stephen · Immunotherapy · 2010
Epstein–Barr virus-associated posttransplant lymphoproliferative disorder after allogeneic stem cell transplantationSanz, Jaime; Andreu, Rafael · Current Opinion in Oncology · 2014
Cutaneous lymphoproliferative disorders associated with Epstein–Barr virus infection: a clinical overviewIwatsuki, Keiji; Xu, Zigang; Ohtsuka, Mikio; Kaneko, Fumio · Journal of Dermatological Science · 2000
Epstein Barr virus-associated lymphoproliferative-disorders primarily involving the skinChiling Chai; Wain L. White; Christopher R. Shea; Victor G. Prieto · 1999